After Battling Diabetes For Nearly 40 Years, Lowe Has Developed Diabetic Retinopathy, A Consequence Of Uncontrolled Diabetes That Can Damage Small Blood Vessels In The Eye And Is The Leading Cause Of Blindness Among Working-age Adults.

After battling diabetes for nearly 40 years, Lowe has developed diabetic retinopathy, a consequence of uncontrolled diabetes that can damage small blood vessels in the eye and is the leading cause of blindness among working-age adults. A researcher across campus from the clinic is looking at a different way of potentially blocking the inflammation that can lead to that damage through a potential new drug. Dr. Shruti Sharma of the Center for Biotechnology and Genomic Medicine has a $1.5 million grant from the National Eye Institute to look at basic research into blocking inflammation among epithelial cells in light-sensing retina in the eye, Sharma is looking at a well-known agent in inflammation called interleukin-6 that can affect those cells even though they lack the receptor normally needed for such interaction, an effect called trans-signaling. While that effect had been known for a while it is not something that researchers had focused on in the past, she said. Sharma is looking at an experimental drug that in her early work seems to have blocked that type of action in those cells, using it both in the lab in human cells in the same kind of environment that is there in the eye and in a mouse model of diabetes. The hope is to prevent the barrier disruption to the cells that can cause them to become leaky and create inflammation, an early hallmark of the disease. http://dclakers.com/advisingeyesurgeon/2016/12/05/a-closer-look-at-strategies-of-cataracts/The mouse model allows Sharma to test the compound in both late and early stages of the disease to see if it she can prevent diabetic retinopathy from happening, she said. Separately, the compound is being tested in human clinical trials in rheumatoid arthritis, which is also promising, Sharma said. Im more excited because I am re-purposing this drug, she said. I am not trying to develop a new drug. But that potential is why Augusta University has translational programs to try and bring those promising research ideas to the clinic, said Nussbaum , chair of the Department of Ophthalmology.

For the original version including any supplementary images or video, visit http://www.washingtontimes.com/news/2017/jan/1/new-drug-might-help-with-diabetes-related-blindnes/?utm_source=RSS_Feed&utm_medium=RSS

You.nd.our ophthalmologist can discuss the cataract surgery procedure, preparation for and recovery after surgery, benefits and possible complications of cataract surgery, cataract surgery costs and other important information. When a cataract is small, the cloudiness affects only a small part of the lens. By Gretchen Bailey ; reviewed by Vance Thompson, MD A cataract is a clouding of the eye’s natural lens, which lies behind the iris and the pupil . Are there different types of cataract? The choices for treating cataracts in children depend on how likely the cataracts are to interfere with the development of normal vision . What can I do if I already have lost some vision from cataract? Scientists Working on Eye Drops to Dissolve Cataracts August 2015 — Cataract surgery is proven to be safe and effective, with a low risk of serious complications. Another option is to choose one of a variety of advanced presbyopia-correcting cols to improve your reading vision without sacrificing your distance vision.

When the protein clumps up, it clouds the lens and reduces the light that reaches the retina. Cataract is detected through a comprehensive eye exam that includes: Visual acuity test. Cataracts can develop after an eye injury, sometimes years later. This may cause a painful form of glaucoma and inflammation inside the eye. Congenital cataracts, which are present at birth or form during a baby’s first year, are less common than age-related cataracts. Dietary carotenoids, vitamins C and E, and risk of cataract in women: A prospective study. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17. no dataIn special cases, an IOU might be placed in front of the iris and pupil, but this is less common. However, as the cataract continues to become denser, vision also becomes more cloudy, and stronger glasses or contact lenses will no longer improve sight. Although some stop growing, they don’t get smaller on their own. In addition to cols that correct near-sightedness and far-sightedness, there are now Dorics cols that correct astigmatism as well. Double vision or multiple images in one eye. If an individual’s eyesight grows…

Leave a Reply

Your email address will not be published. Required fields are marked *